doi:10.1097/fbp.0000000000000818 16.Garvey WT, Blher M, Osorto Contreras CK, et al
After washing away the excess DCFH-DA, the BMSCs were imaged using a fluorescence microscope (Nikon, Tokyo, Japan)
Based on the available data, short-term effects related to MT-I and MT-II consist of the following [5, 18]: Nausea Facial flushing Fatigue Dizziness In addition, clinical studies on MT-II have reported several other specific side effects [19, 23]: Yawning Stretching Spontaneous erections Prolonged, painful erections (priapism) The administration of MT-I and MT-II can rarely cause reactions at the injection site, such as redness, swelling, and bleeding
[10] [11] Clinicians often assess baseline retinopathy status before initiating GLP-1 therapy in high-risk individuals